MedPath

Multicentre Clinical Trial. Project EXIMe

Not Applicable
Completed
Conditions
Menopause
Interventions
Other: Complex intervention in sexual health
Other: Usual care
Registration Number
NCT03558451
Lead Sponsor
Gerencia de Atención Primaria, Madrid
Brief Summary

Objective: to evaluate the effectiveness of an individualized intervention in sexual health conducted in the midwife consultation to improve the quality of life in women with Genitourinary Syndrome of Menopause. Design: Multicentre randomized clinical trial with groups in parallel, controlled single-blind, with blind evaluation of the response variable, held in the Community of Madrid.

Detailed Description

Genitourinary Syndrome of Menopause is a common condition that increases by four the risk of having a sexual dysfunction, and that affects the quality of life of women who suffer it. Those women with an active sexual life have fewer symptoms associated with this syndrome. Objective: to evaluate the effectiveness of an individualized intervention in sexual health conducted in the midwife consultation to improve the quality of life in women with Genitourinary Syndrome of Menopause. Design: Multicentre randomized clinical trial with groups in parallel, controlled single-blind, with blind evaluation of the response variable, held in the Community of Madrid. Population: women aged between 45-65 years with Genitourinary Syndrome of Menopause attending to the midwife consultation. N= 250 (125 women in each group) will be included by midwifes in the Primary Health Care consultations in the Community of Madrid. Control group: women will receive the usual assistance.

Experimental group: in addition to the usual assistance, women will receive a complex intervention in sexual health, individualized, in the midwife consultation, where techniques for expression, analysis, information and development of sexual health skills will be used. Variables: Main-Quality of life in menopause (measured with the Cervantes Short-Form Scale). Secondary- sociodemographic variables, sexual history and variables related to the Genitourinary Syndrome of Menopause. Analysis: by intention-to-treat, comparing the quality of life in menopause scores before/after the intervention in both groups after 0, 1 and 6 months. To explain the factors associated with a higher quality of life, a linear regression model would be fitted.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
250
Inclusion Criteria
  • women aged between 45-65 years with Genitourinary Syndrome of Menopause
Exclusion Criteria
  • women who present pathologies that lead to an alteration of sexual desire
  • women who receive or have received in the last six months treatment that increase the incidence of vaginal atrophy
  • women who receive or have received local hormonal therapy during the last month, systemic hormonal therapy in the last six months, or other systemic treatment for the Genitourinary Syndrome of Menopause
  • women who could not read or write, and not understand the spanish language.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
EXIMe interventionComplex intervention in sexual healthIn addition to the usual assistance, women will receive a complex intervention in sexual health, individualized, in the midwife consultation, where techniques for expression, analysis, information and development of sexual health skills will be used.
EXIMe interventionUsual careIn addition to the usual assistance, women will receive a complex intervention in sexual health, individualized, in the midwife consultation, where techniques for expression, analysis, information and development of sexual health skills will be used.
Usual careUsual careUsual care according to available protocols applicable to the women and the health service standardized portfolio
Primary Outcome Measures
NameTimeMethod
Main-Quality of life in menopauseChange from baseline Quality of life at six months

Main-Quality of life in menopause measured with "Cervantes Short-Form Scale" (20 -100 points)

Secondary Outcome Measures
NameTimeMethod
Urine sedimentChange from baseline at six months

Urine sediment

Sexual functionChange from baseline at six months

Sexual function: measured with Questionnaire "Health and female sexual dysfunction in primary care"

vaginal pHChange from baseline at six months

vaginal pH

Oxford scaleChange from baseline at six months

Oxford scale: pelvic floor muscle response

Trial Locations

Locations (1)

Gerencia de Atención Primaria, Madrid

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath